Form 483

Baxter Healthcare Corporation Form 483, 2025-09-29

FDA issued a Form 483 to Baxter Healthcare Corporation on 2025-09-29 with 5 public-safe observations.

483· Form 483 issuedHuman Drugs5 observations

Baxter Healthcare Corporation · Cleveland, United States · Issued September 29, 2025

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

29 Sep 2025
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Camerson E Moore

29 Sep 2025
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Camerson E Moore

29 Sep 2025
21 CFR 211.58

Buildings not maintained in good state of repair

Cited by Camerson E Moore

29 Sep 2025
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Camerson E Moore

29 Sep 2025
21 CFR 211.68(b)

Backup data not assured as exact and complete

Cited by Camerson E Moore

Inspected site

BHBaxter Healthcare CorporationCleveland, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.58Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 5 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere